Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (7,993,795)	$ (4,445,145)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	596,975	291,370
Interest expense on convertible debt		8,354
Interest expense on PPP loan		3,174
Loss on disposal of asset	41	2,897
Bad debt expense	51,536	30,000
Inventory obsolescence	251,826	318,076
Share-based compensation	2,668,892	1,402,897
Noncash lease expense	174,955	117,598
Loss on equity method investment	616,927
Debt forgiveness, including interest		(586,174)
Changes in operating assets and liabilities:
Accounts receivable	(695,018)	(961,462)
Accounts receivable - related party	(79,787)
Inventory	(1,151,764)	(719,810)
Prepaid and other assets	(305,501)	(449,915)
Accounts payable	166,903	(66,253)
Accounts payable - related parties	(67,772)	154,921
Accrued royalties and expenses	204,005	(25,870)
Accrued bonus and commissions	747,051	890,824
Net cash used in operating activities	(4,814,526)	(4,034,518)
Cash flows from investing activities:
Purchase of property and equipment	(171,867)	(544,374)
Purchase of intangible assets	(578,586)	(1,100,000)
Investment in equity securities	(4,534,278)	(1,100,000)
Net cash used in investing activities	(5,284,731)	(2,744,374)
Cash flows from financing activities:
Draw on line of credit	800,000
Pay off line of credit	(800,000)
Proceeds from PPP Loan		583,000
Public offering net proceeds	28,939,257
Net settlement of equity-based awards	(442,525)
Common stock issued for Employee Stock Purchase Plan		39,330
Distribution to noncontrolling interest member	(200,000)
Net cash provided by financing activities	28,296,732	622,330
Net increase (decrease) in cash	18,197,475	(6,156,562)
Cash, beginning of period	455,366	6,611,928
Cash, end of period	18,652,841	455,366
Cash paid during the period for:
Interest	711
Income taxes
Supplemental noncash investing and financing activities:
Common stock issued for conversion of Series F Preferred Stock		11,368,150
Common stock issued for conversion of related party debt and interest		1,611,911
Common stock issued for asset acquisitions	2,334,244	750,000
License agreement as capital contribution from noncontrolling interest member	$ 93,879